ATE285224T1 - Methode zur prävention und behandlung von dehnungsstreifen (striae distensae) und deren verwendung in dermatologie - Google Patents

Methode zur prävention und behandlung von dehnungsstreifen (striae distensae) und deren verwendung in dermatologie

Info

Publication number
ATE285224T1
ATE285224T1 AT99970017T AT99970017T ATE285224T1 AT E285224 T1 ATE285224 T1 AT E285224T1 AT 99970017 T AT99970017 T AT 99970017T AT 99970017 T AT99970017 T AT 99970017T AT E285224 T1 ATE285224 T1 AT E285224T1
Authority
AT
Austria
Prior art keywords
striae
dermatology
prevention
treatment
stretch marks
Prior art date
Application number
AT99970017T
Other languages
English (en)
Inventor
Philippe Msika
Original Assignee
Expanscience Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Expanscience Lab filed Critical Expanscience Lab
Application granted granted Critical
Publication of ATE285224T1 publication Critical patent/ATE285224T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/011—Hydrolysed proteins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/645—Proteins of vegetable origin; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9706—Algae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
AT99970017T 1998-10-05 1999-10-05 Methode zur prävention und behandlung von dehnungsstreifen (striae distensae) und deren verwendung in dermatologie ATE285224T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9812435A FR2784029B1 (fr) 1998-10-05 1998-10-05 Methode de prevention et/ou de traitement cosmetique des vergetures de la peau et utilisation en dermatologie
PCT/FR1999/002375 WO2000019974A1 (fr) 1998-10-05 1999-10-05 Methode de prevention et/ou de traitement cosmetique des vergetures de la peau et utilisation en dermatologie

Publications (1)

Publication Number Publication Date
ATE285224T1 true ATE285224T1 (de) 2005-01-15

Family

ID=9531192

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99970017T ATE285224T1 (de) 1998-10-05 1999-10-05 Methode zur prävention und behandlung von dehnungsstreifen (striae distensae) und deren verwendung in dermatologie

Country Status (13)

Country Link
EP (1) EP1119344B1 (de)
KR (1) KR100568007B1 (de)
AT (1) ATE285224T1 (de)
AU (1) AU5989499A (de)
CA (1) CA2346384C (de)
DE (1) DE69922819T2 (de)
ES (1) ES2234336T3 (de)
FR (1) FR2784029B1 (de)
HK (1) HK1039271A1 (de)
MX (1) MXPA01003518A (de)
PL (1) PL347095A1 (de)
PT (1) PT1119344E (de)
WO (1) WO2000019974A1 (de)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2802413B1 (fr) * 1999-12-17 2003-10-31 Sederma Sa Compositions cosmetiques ou dermopharmaceutiques contenant le tripeptide n-palmytoyl-gly-hys-lys, pour eliminer, reduire ou prevenir l'apparition de rides quelles qu'en soient la localisation et la cause
FR2811892B1 (fr) * 2000-07-18 2003-04-18 Oreal Composition comprenant un extrait de sophora japonica et utilisation
WO2002049656A1 (fr) * 2000-12-19 2002-06-27 Kabushiki Kaisha Yakult Honsha Preparations externes pour la peau et leur procede de production
FR2825918B1 (fr) * 2001-06-14 2005-01-21 Alfred Denner Procede cosmetique du traitement des vergetures
FR2827170B1 (fr) 2001-07-13 2004-07-16 Soc Extraction Principes Actif Utilisation de peptides pour augmenter l'adhesion cellulaire
ITMI20020147A1 (it) 2002-01-29 2003-07-29 Indena Spa Estrazione purificazione e modificazione di polipeptidi da seme di soia
FR2856294B1 (fr) 2003-06-18 2005-08-05 Expanscience Lab Utilisation cosmetique d'une composition comprenant au moins une oxazoline, a titre de principe actif, comme amincissant et/ou pour prevenir et/ou traiter la cellulite
WO2005048968A1 (en) * 2003-11-17 2005-06-02 Sederma Compositions containing mixtures of tetrapeptides and tripeptides
KR100656807B1 (ko) * 2005-02-23 2006-12-13 배석년 구연산, 아연 및 아르기닌으로 이루어진 팽창선조 예방 및치료용 조성물
JP2008074788A (ja) * 2006-09-22 2008-04-03 Rohto Pharmaceut Co Ltd エラスチン産生促進剤
KR100846356B1 (ko) * 2007-11-27 2008-07-15 신라대학교 산학협력단 파래 속 추출물을 포함하는 항진균 조성물
FR2938192B1 (fr) 2008-11-07 2012-08-24 Expanscience Lab Nouvel actif anti-vergetures et compositions le comprenant
FR2939039B1 (fr) 2008-12-01 2010-12-31 Basf Beauty Care Solutions France Sas Nouvel agent inhibiteur de secretion de sebum
FR2954702B1 (fr) 2009-12-31 2013-07-05 Basf Beauty Care Solutions F Agent stimulant l'expression de loxl
FR2973246B1 (fr) 2011-03-31 2013-04-12 Nuxe Lab Composition a base de camellia japonica pour la protection de la peau.
FR2977797B1 (fr) 2011-07-13 2014-01-17 Urgo Lab Utilisation cosmetique et/ou dermatologique de composes oligosaccharidiques pour la prevention et le traitement des vergetures
FR2994387B1 (fr) 2012-08-13 2016-07-29 Basf Beauty Care Solutions France Sas Ingredient hydratant cosmetique ou pharmaceutique
FR3003758B1 (fr) 2013-03-27 2015-07-17 Basf Beauty Care Solutions France Sas Utilisation cosmetique ou dermatologique d'un extrait de polygonum bistorta
FR3010314B1 (fr) 2013-09-12 2017-05-05 Basf Beauty Care Solutions France Sas Utilisation cosmetique ou dermatologique d'un extrait de tapirira guyanensis
FR3030275B1 (fr) 2014-12-23 2018-03-02 Basf Beauty Care Solutions France Sas Utilisation d'un extrait de lythrum salicaria
FR3049859B1 (fr) 2016-04-12 2023-11-03 Basf Beauty Care Solutions France Sas Utilisation cosmetique d'un extrait de khaya senegalensis
FR3055799B1 (fr) 2016-09-15 2020-06-19 Basf Beauty Care Solutions France Sas Nouvelle utilisation cosmetique et/ou nutraceutique ou dermatologique d'un extrait de levure
FR3058641B1 (fr) 2016-11-17 2019-11-01 Basf Beauty Care Solutions France Sas Utilisation cosmetique, nutraceutique ou pharmaceutique preferentiellement dermatologique d'un extrait de feuilles de la plante lansium domesticum pour diminuer la pigmentation de la peau et/ou des annexes cutanees
FR3061015B1 (fr) 2016-12-23 2019-09-20 Basf Beauty Care Solutions France Sas Utilisation cosmetique d'un extrait de corchorus olitorius
FR3065876B1 (fr) 2017-05-05 2020-08-14 Basf Beauty Care Solutions France Sas Utilisation d'un extrait de nephelium lappaceum pour augmenter la fermete de la peau et/ou des muqueuses
FR3069162A1 (fr) 2017-07-24 2019-01-25 Basf Beauty Care Solutions France Sas Extrait aqueux de momordica cochinchinensis pour maintenir et/ou augmenter l'expression des kindlines de la peau et des muqueuses
FR3097127B1 (fr) 2017-10-03 2022-09-16 Basf Beauty Care Solutions France Sas Procédé d’utilisation d’un inhibiteur de Let-7b en cosmétique et/ou en nutraceutique
FR3071742B1 (fr) 2017-10-03 2020-07-10 Basf Beauty Care Solutions France Sas Procede d'utilisation d'un inhibiteur de let-7b en cosmetique et/ou en nutraceutique
FR3082122B1 (fr) 2018-06-11 2021-01-01 Basf Beauty Care Solutions France Sas Utilisation d'un extrait de bixa orellana
FR3085839A1 (fr) 2018-09-13 2020-03-20 Basf Beauty Care Solutions France Sas Utilisation de phytosterols
FR3092493A1 (fr) 2019-02-12 2020-08-14 Dermaconcept Jmc Composition cosmétique et/ou dermatologique pour lutter contre les vergetures
FR3093644B1 (fr) 2019-03-12 2021-07-02 Basf Beauty Care Solutions France Sas Nouvelle utilisation cosmétique de sphères poreuses d’oxyde métallique
FR3098405B1 (fr) 2019-07-12 2021-06-25 Expanscience Lab Composition comprenant des polyphénols de graines de passiflore, des peptides d’avocat et un extrait d’hamamélis et utilisation pour traiter et/ou prévenir les vergetures
FR3099702B1 (fr) 2019-08-08 2022-03-25 BASF Beauty Care Solutions FR Nouvelle utilisation cosmétique d’un extrait d’Epilobium angustifolium
FR3099701B1 (fr) 2019-08-08 2022-03-25 BASF Beauty Care Solutions FR Nouvelle utilisation cosmétique d’une combinaison d’oenothéine-B et de quercétine-3-O-glucuronide
FR3125967A1 (fr) 2021-08-06 2023-02-10 Basf Beauty Care Solutions France Sas Utilisations cosmétiques contre la lumière bleue de microsphères poreuses d’oxyde métallique
FR3131838A1 (fr) 2022-01-18 2023-07-21 Basf Beauty Care Solutions France Sas Nouvelle utilisation cosmétique de sphères poreuses à porosité fermée d’oxyde métallique

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5444091A (en) * 1994-05-24 1995-08-22 Dermatology Home Products, Inc. Method of applying alpha hydroxy acids for treating striae distensae
US5759555A (en) * 1996-06-07 1998-06-02 Moy; Lawrence S. Cosmetic formulation and method for amelioration of skin keratoses and striae distensae

Also Published As

Publication number Publication date
EP1119344B1 (de) 2004-12-22
WO2000019974A1 (fr) 2000-04-13
FR2784029B1 (fr) 2001-01-05
MXPA01003518A (es) 2002-09-18
ES2234336T3 (es) 2005-06-16
PT1119344E (pt) 2005-05-31
DE69922819T2 (de) 2005-12-22
PL347095A1 (en) 2002-03-25
CA2346384C (fr) 2011-07-12
DE69922819D1 (de) 2005-01-27
KR20010079997A (ko) 2001-08-22
KR100568007B1 (ko) 2006-04-07
FR2784029A1 (fr) 2000-04-07
AU5989499A (en) 2000-04-26
EP1119344A1 (de) 2001-08-01
HK1039271A1 (en) 2002-04-19
CA2346384A1 (fr) 2000-04-13

Similar Documents

Publication Publication Date Title
ATE285224T1 (de) Methode zur prävention und behandlung von dehnungsstreifen (striae distensae) und deren verwendung in dermatologie
DE69835279D1 (de) Zusammensetzungen und verfahren zur behandlung von infektionen unter verwendung von kationischen peptiden allein oder in kombination mit antibiotika
BR0210282A (pt) Veìculos de distribuição de fosfato de cálcio para proteìnas osteoindutivas
BRPI0213786B8 (pt) peptídeos efetivos no tratamento de tumores e outras condições que requerem a remoção ou destruição de células
ES2178000T3 (es) Composiciones y metodos para tratar infecciones usando analogos de indolicidina.
DE60142839D1 (de) Botulinum Toxin zur Behandlung von akuten Verletzungen der Skelettmuskeln
DE693928T1 (de) Aminozucker- und glykosaminoglykanzusammensetzung zur behandlung und reparatus von bindegewebe
HUP9904023A2 (hu) Leptin antagonisták alkalmazása inzulin rezisztencia kezelésére II. típusú cukorbajban
ATE353914T1 (de) Peptide zur behandlung von tumoren und anderen bedingungen die die entfernung oder zerstörung von zelle erfordern
ATE196246T1 (de) Hautbräunungsmittel
ES2116298T3 (es) Nuevo metodo de tratamiento de la depresion.
DE60031951D1 (de) Methoden zur verwendung von neurotrophin 3 (nt-3) zur behandlung von gastrointestinalen hypomobilitätsstörungen
DE602004016834D1 (de) Zusammensetzung zur vermeidung und behandlung von cellulitis
ATE251631T1 (de) Dipohosphonsäuresalze für die behandlung von osteoporose
ATE225171T1 (de) Aminosäurederivate zur behandlung von schlaganfall
ATE336992T1 (de) Verwendung von alkansäuren-enthaltenden zusammensetzungen zur behandlung von nagelpilz- erkrankungen
ATE272399T1 (de) Zusammensetzungen aus aminosäuren zur behandlung von herzinsuffizienz
ATE359808T1 (de) Verwendung von sarp-1 zur behandlung und/oder vorbeugung von scleroderma
DE69827387D1 (de) Verwendung von pramipexol zur behandlung von restless-legs-syndrom
DE69413637D1 (de) Verwendung von verzweigtkettigen Aminosäuren zur Herstellung eines Arzneimittels zur Behandlung von tardiver Dyskinesia
DE69900774T2 (de) Verwendung von topische präparationen mit glyceryl trinitrat und lanolin zur behandlung von erektilen funktionsstörungen
NO984189L (no) FremgangsmÕte for behandling av bipolar forstyrrelse
DE60128084D1 (de) Verwendung von inaktives cln2 proenzym zur behandlung von lincl
ATE235249T1 (de) Die von morphogenen peptiden hervorgerufene wiederherstellung von gewebe aus sinneszellen
DE69800906T2 (de) Verwendung von Olanzapine zur Herstellung eines Arzneimittels zur Behandlung der zerebralen fokalen Ischämie

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties